Financing ·
GeoVax Labs Inc. entered into a warrant exercise inducement offer on August 25, 2026, with an existing institutional…
GOVXWGeoVax Labs, Inc.
GeoVax Labs Inc. entered into a warrant exercise inducement offer on August 25, 2026, with an existing institutional investor to exercise outstanding warrants for gross cash proceeds of approximately $3,646,482. In exchange, the company issued new unregistered warrants to purchase up to 11,395,256 shares at an exercise price of $0.64 per share. The transaction closed on August 26, 2026, with proceeds designated for working capital and general corporate purposes. GeoVax Labs is a clinical-stage biotechnology company developing vaccines and immunotherapies.